Market Overview

Benzinga's Top Upgrades, Downgrades For January 31, 2019

Share:

Top Upgrades

  • Telsey Advisory Group upgraded Ralph Lauren Corp (NYSE: RL) from Market Perform to Outperform. Ralph Lauren shares rose 0.63 percent to close at $116.95 on Wednesday.
  • Bank of America upgraded Oshkosh Corp (NYSE: OSK) from Neutral to Buy. Oshkosh shares rose 0.3 percent to $73.00 in pre-market trading.
  • Evercore ISI Group upgraded T. Rowe Price Group Inc (NASDAQ: TROW) from In-Line to Outperform. T. Rowe Price shares rose 0.01 percent to $89.25 in pre-market trading.
  • Argus upgraded Pfizer Inc. (NYSE: PFE) from Neutral to Outperform. Pfizer shares rose 0.3 percent to $41.71 in pre-market trading.
  • B. Riley FBR upgraded Geron Corporation (NASDAQ: GERN) from Neutral to Buy. Geron shares rose 11.7 percent to $1.15 in pre-market trading.
  • Bank of America upgraded Helmerich & Payne, Inc. (NYSE: HP) from Neutral to Buy. Helmerich & Payne rose 5.51 percent to close at $56.83 on Perform.
  • Atlantic Equities upgraded Tiffany & Co. (NYSE: TIF) from Neutral to Overweight. Tiffany shares rose 0.41 percent to close at $87.98 on Perform.
  • JP Morgan upgraded Scotts Miracle-Gro Co (NYSE: SMG) from Underweight to Neutral. Scotts Miracle Gro shares rose 2.12 percent to close at $71.44 on Wednesday.
  • Longbow Research upgraded Littelfuse, Inc. (NASDAQ: LFUS) from Neutral to Buy. Littelfuse shares dropped 7.38 percent to close at $170.75 on Wednesday.

 

Top Downgrades

  • Telsey Advisory Group downgraded Steven Madden, Ltd. (NASDAQ: SHOO) from Outperform to Market Perform. Steven Madden shares rose 1.59 percent to close at $32.55 on Wednesday.
  • SunTrust Robinson Humphrey downgraded US Concrete Inc (NASDAQ: USCR) from Buy to Hold. US Concrete shares rose 1.46 percent to close at $37.55 on Wednesday.
  • Bank of America downgraded BT Group plc (NYSE: BT) from Buy to Neutral. BT Group shares fell 1.5 percent to $15.20 in pre-market trading.
  • Credit Suisse downgraded Allergan plc (NYSE: AGN) from Outperform to Neutral. Allergan shares fell 0.85 percent to close at $143.89 on Wednesday.
  • Citigroup downgraded Outfront Media Inc (NYSE: OUT) from Buy to Neutral. Outfront Media shares fell 0.53 percent to close at $20.81 on Wednesday.
  • Barclays downgraded Invesco Ltd. (NYSE: IVZ) from Overweight to Equal-Weight. Invesco shares fell 0.8 percent to $18.45 in pre-market trading.
  • Goldman Sachs downgraded H & R Block Inc (NYSE: HRB) from Neutral to Sell. H&R Block shares fell 4 percent to $24.50 in pre-market trading.
  • Oppenheimer downgraded Credit Acceptance Corp. (NASDAQ: CACC) from Outperform to Market Perform. Credit Acceptance shares rose 1.39 percent to close at $414.37 on Wednesday.
  • Imperial Capital downgraded AMC Networks Inc (NASDAQ: AMCX) from In-Line to Underperform. AMC Networks shares fell 4.01 percent to close at $62.02 on Wednesday.
  • Argus downgraded General Dynamics Corporation (NYSE: GD) from Buy to Hold. General Dynamics shares closed at $170.91 on Wednesday.

 

Top Initiations

  • Analysts at Gordon Haskett initiated coverage on At Home Group Inc (NYSE: HOME) with a Hold rating. The price target for At Home is set to $22. At Home closed at $21.93 on Wednesday.
  • Analysts at Citigroup initiated coverage on Bilibili Inc - ADR (NASDAQ: BILI) with a Buy rating. The price target for Bilibili is set to $22. Bilibili shares closed at $17.76 on Wednesday.
  • Janney Capital assumed coverage on BioDelivery Sciences International, Inc. (NASDAQ: BDSI) with a Buy rating. BioDelivery Sciences shares closed at $4.50 on Wednesday.
  • Credit Suisse initiated coverage on Intercept Pharmaceuticals Inc (NASDAQ: ICPT) with an Outperform rating. The price target for Intercept Pharmaceuticals is set to $167. Intercept Pharmaceuticals shares closed at $116.16 on Wednesday.
  • H.C. Wainwright assumed coverage on Mesoblast limited (NASDAQ: MESO) with a Buy rating. The price target for Mesoblast is set to $6.50. Mesoblast shares closed at $4.56 on Wednesday.
  • Berenberg initiated coverage on Teladoc Health Inc (NYSE: TDOC) with a Buy rating. Teladoc Health shares closed at $62.06 on Wednesday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (AGN + AMCX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VREXNorthland SecuritiesInitiates Coverage On42.0
PFSWCraig-HallumDowngrades0.0
EAMorgan StanleyMaintains88.0
ELMorgan StanleyMaintains178.0
SPLKMorgan StanleyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

BATs Bounce Back, Lift This ETF

Ford, GM Disrupted By Winter Storm As DTE, Consumers Demand Heat Conservation